First regression: Rate of rise of confirmed cases of COVID-19 in 50 countries, and the associated local meteorological and demographic variables. حسب Adam Kaplin (10156481)

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces حسب Guangchao Han (1453198)

K562 cells were treated with 40 nM of miR-214 mimics or a negative mimics control for 24 h, followed by treatment with 50 μM of hemin for 48 h. حسب Tipparat Penglong (164413)

Virchow’s Triad, including hypercoagulability suggested by decreased fibrinogen in placentas exposed to intrauterine inflammation. حسب Solange N. Eloundou (6551627)

MRI imaging and analysis, revealing decreased volume and thickness of placentas exposed to intrauterine inflammation. حسب Solange N. Eloundou (6551627)

Repellency by commercial transfluthrin products consists of both Or-mediated and Or-independent repellency in <i>Ae</i>. <i>aegypti</i>. حسب Felipe Andreazza (11098928)

αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. حسب Daniel P. Bradley (10306893)

الموضوعات:

1466 does not change total yield of capsids during biochemical assembly reactions. حسب Daniel P. Bradley (10306893)

الموضوعات:

HPD compounds 1736 and 1740 also suppress accumulation of HBV capsids. حسب Daniel P. Bradley (10306893)

الموضوعات:

Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. حسب Daniel P. Bradley (10306893)

الموضوعات:

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. حسب Daniel P. Bradley (10306893)

الموضوعات:

1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. حسب Daniel P. Bradley (10306893)

الموضوعات:

Differences among the classes of CAMs. حسب Daniel P. Bradley (10306893)

الموضوعات:

HBV replication cycle with modeled activity of 1466, a bimodal HBV RNaseH-CAM-I Inhibitor, and other small molecule inhibitors used in this study. حسب Daniel P. Bradley (10306893)

الموضوعات:

Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. حسب Daniel P. Bradley (10306893)

الموضوعات:

1466 does not induce disassembly of pre-formed HBV capsids in cell lysates. حسب Daniel P. Bradley (10306893)

الموضوعات:

1466 inhibits capsid accumulation independent of HBV replication. حسب Daniel P. Bradley (10306893)

الموضوعات:

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. حسب Daniel P. Bradley (10306893)

الموضوعات:

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. حسب Daniel P. Bradley (10306893)

الموضوعات:

Half maximal inhibitory concentrations (IC₅₀) of selected compounds. حسب Samo Lešnik (21073880)